Abstract:Background: Recent studies have highlighted the significant role of the NF-κB signaling pathway in the initiation and progression of cancer. Furthermore, long noncoding RNAs (lncRNAs) have been identified as pivotal regulators in sustaining the NF-κB signaling pathway's functionality. Despite these findings, the underlying molecular mechanisms through which lncRNAs influence the NF-κB pathway remain largely unexplored. Methods: Bioinformatic analyses were utilized to investigate the differential expression and prognostic significance of XTP6. The functional roles of XTP6 were further elucidated through both in vitro and in vivo experimental approaches. To estimate the interaction between XTP6 and NDH2, RNA pulldown and RNA Immunoprecipitation (RIP) assays were conducted. The connection between XTP6 and the IκBα promoter was examined using Chromatin Isolation by RNA Purification (ChIRP) assays. Additionally, Chromatin Immunoprecipitation (ChIP) assays were implemented to analyze the binding affinity of c-myc to the XTP6 promoter, providing insights into the regulatory mechanisms at play. Results: XTP6 was remarkedly upregulated in glioblastoma multiforme (GBM) tissues and was connected with adverse prognosis in GBM patients. Our investigations revealed that XTP6 can facilitate the malignant progression of GBM both in vitro and in vivo. Additionally, XTP6 downregulated IκBα expression by recruiting NDH2 to the IκBα promoter, which resulted in elevated levels of H3K27me3, thereby reducing the transcriptional activity of IκBα. Moreover, the progression of GBM was further driven by the c-myc-mediated upregulation of XTP6, establishing a positive feedback loop with IκBα that perpetuated the activation of the NF-κB signaling pathway. Notably, the application of an inhibitor targeting the NF-κB signaling pathway effectively inhibited the continuous activation induced by XTP6, leading to a significant reduction in tumor formation in vivo. Conclusion: The results reveal that XTP6 unveils an innovative epigenetic mechanism instrumental in the sustained activation of the NF-κB signaling pathway, suggesting a promising therapeutic target for the treatment of GBM.

Retraction Note: MYC-mediated Upregulation of PNO1 Promotes Glioma Tumorigenesis by Activating THBS1/FAK/Akt Signaling

PNO1 promotes human cholangiocarcinoma tumorigenesis and chemosensitivity

PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway

Pan-cancer exploration of PNO1: A prospective prognostic biomarker with ties to immune infiltration

Notch1 is a Prognostic Factor That is Distinctly Activated in the Classical and Proneural Subtype of Glioblastoma and That Promotes Glioma Cell Survival Via the NF-κB(p65) Pathway

A novel promoter-associated non-coding small RNA paGLI1 recruits FUS/ P65 to transactivate GLI1 gene expression and promotes infiltrating glioma progression

Netrin-1 Promotes Glioma Growth by Activating NF-κB Via UNC5A

Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma

Knockdown of Nupr1 Inhibits the Proliferation of Glioblastoma Cells Via Erk1/2, P38 Mapk and Caspase-3

PROX1 promotes human glioblastoma cell proliferation and invasion via activation of the nuclear factor-κB signaling pathway.

Knockdown of NOB1 Expression by RNAi Inhibits Cellular Proliferation and Migration in Human Gliomas.

Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1

Protein Phosphatase 1γ Regulates the Proliferation of Human Glioma Via the NF-κB Pathway

NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation

PHLDA1 Promotes Glioblastoma Oncogenesis via Ras/Mek/Erk Signaling Pathway

Knockdown of NUSAP1 Inhibits Cell Proliferation and Invasion Through Down-Regulation of TOP2A in Human Glioblastoma

Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma

Suppression of PTTG1 Inhibits Cell Angiogenesis, Migration and Invasion in Glioma Cells

High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.

POFUT1 Acts As a Tumor Promoter in Glioblastoma by Enhancing the Activation of Notch Signaling

Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma